Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.179
-0.003 (-1.43%)
Apr 26, 2024, 4:00 PM EDT - Market closed

MTNB Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Net Income
-22.94-21-23.68-23.24-18.3-14.99-32.84-11.99-9.14-10.22
Upgrade
Depreciation & Amortization
0.940.90.780.770.780.220.10.050.040.04
Upgrade
Share-Based Compensation
4.955.234.294.562.993.833.61.521.591.97
Upgrade
Other Operating Activities
1.78-4.292.99-0.26-0.49-0.290.33-0.09-0.310.24
Upgrade
Operating Cash Flow
-15.28-19.16-15.22-17.37-14.09-10.32-11.46-6.12-7.81-7.96
Upgrade
Capital Expenditures
-0.22-0.89-0.26-0.01-0.41-0.54-0.940-0.08-0.29
Upgrade
Acquisitions
000000000.070
Upgrade
Change in Investments
13.465.7717.03-40.66-5.6100000
Upgrade
Investing Cash Flow
13.244.8816.77-40.67-6.01-0.54-0.940-0.01-0.29
Upgrade
Share Issuance / Repurchase
00.1748.130.139.2415.9508.510
Upgrade
Debt Issued / Paid
-0.01-0.02-0.03-0.05-0.28-0.43-0.35-0.16-0.060
Upgrade
Other Financing Activities
-----7.06-7.16--
Upgrade
Financing Cash Flow
-0.010.086.9748.0529.8515.8715.678.460
Upgrade
Net Cash Flow
-2.04-14.28.51-9.999.755.013.20.880.64-8.25
Upgrade
Free Cash Flow
-15.5-20.05-15.48-17.37-14.5-10.86-12.4-6.12-7.89-8.25
Upgrade
Free Cash Flow Margin
-1413.87%-628.86%-46918.18%-------
Upgrade
Free Cash Flow Per Share
-0.07-0.09-0.07-0.09-0.10-0.11-0.14-0.11-0.15-0.26
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).